An Inducible and Reversible Mouse Genetic Rescue System

Inducible and reversible regulation of gene expression is a powerful approach for uncovering gene function. We have established a general method to efficiently produce reversible and inducible gene knockout and rescue in mice. In this system, which we named iKO, the target gene can be turned on and off at will by treating the mice with doxycycline. This method combines two genetically modified mouse lines: a) a KO line with a tetracycline-dependent transactivator replacing the endogenous target gene, and b) a line with a tetracycline-inducible cDNA of the target gene inserted into a tightly regulated (TIGRE) genomic locus, which provides for low basal expression and high inducibility. Such a locus occurs infrequently in the genome and we have developed a method to easily introduce genes into the TIGRE site of mouse embryonic stem (ES) cells by recombinase-mediated insertion. Both KO and TIGRE lines have been engineered for high-throughput, large-scale and cost-effective production of iKO mice. As a proof of concept, we have created iKO mice in the apolipoprotein E (ApoE) gene, which allows for sensitive and quantitative phenotypic analyses. The results demonstrated reversible switching of ApoE transcription, plasma cholesterol levels, and atherosclerosis progression and regression. The iKO system shows stringent regulation and is a versatile genetic system that can easily incorporate other techniques and adapt to a wide range of applications.

[1]  Hongkui Zeng,et al.  Large-scale, saturating insertional mutagenesis of the mouse genome , 2007, Proceedings of the National Academy of Sciences.

[2]  Ali H. Cetin,et al.  Silencing and Un-silencing of Tetracycline-Controlled Genes in Neurons , 2007, PloS one.

[3]  R. Brough,et al.  Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics , 2007, BMC Molecular Biology.

[4]  G. Felsenfeld,et al.  Insulators: exploiting transcriptional and epigenetic mechanisms , 2006, Nature Reviews Genetics.

[5]  S. Schwartz,et al.  Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. , 2006, The American journal of pathology.

[6]  F. Tacke,et al.  Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Lowe,et al.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.

[8]  S. Elledge,et al.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Raffai,et al.  Apolipoprotein E Promotes the Regression of Atherosclerosis Independently of Lowering Plasma Cholesterol Levels , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Barrot,et al.  Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Sharp,et al.  Cre-lox-regulated conditional RNA interference from transgenes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Smaroula Dilioglou,et al.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector , 2004, Nature Biotechnology.

[13]  M. Hu,et al.  Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Hermann Bujard,et al.  Studying gene function in eukaryotes by conditional gene inactivation. , 2002, Annual review of genetics.

[15]  N. Daigle,et al.  A predictable ligand regulated expression strategy for stably integrated transgenes in mammalian cells in culture. , 2002, Gene.

[16]  René Hen,et al.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult , 2002, Nature.

[17]  M. Lewandoski.  Conditional control of gene expression in the mouse , 2001, Nature Reviews Genetics.

[18]  P. Chambon,et al.  An efficient system for conditional gene expression in embryonic stem cells and in their in vitro and in vivo differentiated derivatives , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Fussenegger,et al.  Streptogramin-based gene regulation systems for mammalian cells , 2000, Nature Biotechnology.

[20]  P. Seeburg,et al.  Respiration and parturition affected by conditional overexpression of the Ca2+-activated K+ channel subunit, SK3. , 2000, Science.

[21]  R. Walzem,et al.  Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[22]  S. Tilghman,et al.  The temporal requirement for endothelin receptor-B signalling during neural crest development , 1999, Nature.

[23]  D. Rader,et al.  Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Kelz,et al.  Transgenic animals with inducible, targeted gene expression in brain. , 1998, Molecular pharmacology.

[25]  L A Herzenberg,et al.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Yaolin Wang,et al.  Ligand-inducible and liver-specific target gene expression in transgenic mice , 1997, Nature Biotechnology.

[27]  E. Kandel,et al.  Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.

[28]  P Chambon,et al.  Ligand-activated site-specific recombination in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Gossen,et al.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Evans,et al.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Hennighausen,et al.  Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive system , 1995, Journal of Cellular Biochemistry.

[32]  L. Curtiss,et al.  Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. , 1995, The Journal of clinical investigation.

[33]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[34]  D J Porteous,et al.  Splinkerettes--improved vectorettes for greater efficiency in PCR walking. , 1995, Nucleic acids research.

[35]  S. Fazio,et al.  Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.

[36]  P. Swiatek,et al.  Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. , 1993, Genes & development.

[37]  G. Felsenfeld,et al.  A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila , 1993, Cell.

[38]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[39]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[40]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.